ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,653.00
12.50 (0.76%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  12.50 0.76% 1,653.00 1,654.00 1,655.00 1,655.50 1,634.00 1,638.50 3,990,601 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.83 68.14B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,640.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £68.14 billion. Gsk has a price to earnings ratio (PE ratio) of 13.83.

Gsk Share Discussion Threads

Showing 25226 to 25248 of 33100 messages
Chat Pages: Latest  1012  1011  1010  1009  1008  1007  1006  1005  1004  1003  1002  1001  Older
DateSubjectAuthorDiscuss
05/3/2021
08:49
Shareholders own the company directors manage the company, I'm amazed shareholders just rolling over and let Walmsley do what she wants. Cutting the dividend is a cardinal sin for income seekers.
montyhedge
05/3/2021
08:37
To appoint her from within was a huge mistake, that is history, but watching this company being suffocated before being consumed is an absolute shocker. It is a wanton act of corporate murder!
wormhasturned
05/3/2021
08:17
She wants to cut the dividend which upsets 99% of investors I would say.
montyhedge
05/3/2021
08:12
Does the fool leading this company not listen to her largest shareholders, because if she did she might be aware that they disapprove of value destruction. I am sure that they do not solely think of the dividend contribution, but more the cost of that dividend to the stability of the company. Why she was appointed to the role of CEO is beyond, and it is clear she is a woman with a complete lack of empathy as she has not acknowledged that GSK will cease to exist post the separation. For a company that has amalgamated from the the Wellcome, SmithKline Beecham and Glaxo Organisation organisations, it is shocking to see the failures that management has achieved in terms of value to the company that resulted. Splitting may be obvious but at what cost!
wormhasturned
04/3/2021
16:25
Beating Astra in percentage terms today.
montyhedge
04/3/2021
16:00
ulvr does better in weaker markets, risk off.
solid.

careful
04/3/2021
15:50
ULVR is also up 1.6%
kev0856153
04/3/2021
15:46
If it closes above 1225p that's strong, if not may drift back tomorrow.
montyhedge
04/3/2021
15:43
Hopefully today will end strong blue and above the recent range
supermarky
04/3/2021
15:28
Good run today.
montyhedge
04/3/2021
15:20
I wish, my dividend reinvestment plan it would work wonders.
montyhedge
04/3/2021
15:17
who is still waiting for 1125?
eurofox
04/3/2021
15:00
London, 15 January 2021 – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that it has temporarily paused the launch of its generic version of GlaxoSmithKline̵7;s Advair Diskus®

Technicality with change of packaging: Hikma has submitted to the US FDA an amendment to its application. The amendment reflects enhanced packaging controls to meet new industry standards adopted since the initial submission of its ANDA application.

tradermichael
04/3/2021
14:52
I thought Hikma Pharma started the generic version of Advair in February? What's happened.
montyhedge
04/3/2021
14:00
Yes if you paid 1375p unlucky.
montyhedge
04/3/2021
13:48
Average price here at the moment 1204
eurofox
04/3/2021
13:47
Assuming your average is 1200p not substantially higher as is the case with most holders here. spud
spud
04/3/2021
11:24
No vaccine for HSV-1 that I'm aware of, GSK offer acyclovir or the "newer" valaciclovir in tablet form.
essentialinvestor
04/3/2021
11:15
Given how so many pension funds are invested in large/fairly large dividend paying stocks, I wonder if the Corporate Tax changes will have much of an impact on the trading strategy of said funds?
Will more of them move towards buying high growth (and high R&D investment-focused companies), or will it just become another accounting exercise for the big players to navigate, whereby only the SME's pay anywhere close to 25% CT?
I think I already know the answer to this one...
Either way, hopefully GSK will no longer be languishing at that point, split or otherwise.

lovewinshatelosses
04/3/2021
11:03
"At least its bosses promise another 80p for 2021. The intuitive response might be to tell Glaxo to stick it, but that would be silly. After all, with the share price down to £12.70, the dividend yields 6.3 per cent. Which leaves holding Glaxo’s shares feeling a bit like having herpes – easier to acquire than to be rid of, even though Glaxo does have a vaccine – but I am itching to be rid of them."



Well, you may call it a rash (pun intended) decision, but I increased my GSK holding by 50% last week at just over 1200p.

mister md
04/3/2021
11:01
All drug company share are down due to less operations be carried out .Don't panic guys time to buy

Remember buy cheap sell on the up

notbitcoin
04/3/2021
10:58
GSK's 130% capital allowances would more than offset the increase in CT.
ianood
04/3/2021
10:46
GSK has a program to tackle Respiratory Syncytial Virus Infections. Vaccine trials are progressing well, with huge potential in India, Japan etc. to combat this seasonal epidemic.
tradermichael
Chat Pages: Latest  1012  1011  1010  1009  1008  1007  1006  1005  1004  1003  1002  1001  Older

Your Recent History

Delayed Upgrade Clock